The invention relates to methods of treating or preventing obesity, type 2 diabetes, metabolic syndrome, or glucose intolerance using pyrido[3,2-e]pyrazines which are inhibitors of PDE10. The invention further relates to methods of reducing body fat or body weight.

 
Web www.patentalert.com

< Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10

> Quinoline Derivatives as Neurokinin Receptor Antagonists

> SCALABLE SYNTHESIS OF IMIDAZOLE DERIVATIVES

~ 00523